Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Changes in Shareholders' Equity

v3.22.4
Consolidated Statements of Changes in Shareholders' Equity - USD ($)
$ in Thousands
Common Shares
Additional Paid-in Capital
Warrants
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Non-Controlling Interest
Total
Balance at beginning of period at Dec. 31, 2020 $ 851,851 $ 223,499 $ 6,757 $ 1,014 $ (818,436)   $ 264,685
Balance at beginning of period (in shares) at Dec. 31, 2020 367,182,673            
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Options exercised $ 13           13
Options exercised (Shares) 221,400            
Share-based compensation   1,240         1,240
Warrants exercised $ 173 96         269
Warrants exercised (in shares) 657,000            
Warrants reclassified to liability     (5,805)   (2,686)   (8,491)
Issuance and vesting of restricted share units $ 2,192           2,192
Issuance and vesting of restricted share units (in shares) 5,272,310            
Shares reserved for performance awards $ 372           372
Shares issued for SFNY business combination $ 351           351
Shares issued for SFNY business combination (Shares) 749,376            
Non-controlling interest           $ 175 175
Comprehensive income (loss) for the period       (15) (35,126)   (35,141)
Balance at end of the period at Dec. 31, 2021 $ 854,952 224,835 952 999 (856,248) 175 225,665
Balance at end of period (in shares) at Dec. 31, 2021 374,082,759            
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Share-based compensation   136         136
Warrants expired   156 (156)        
Issuance and vesting of restricted share units $ 2,329           2,329
Issuance and vesting of restricted share units (in shares) 3,432,632            
Shares reserved for performance awards $ 862           862
Comprehensive income (loss) for the period       (11) (107,455) (9) (107,475)
Balance at end of the period at Dec. 31, 2022 $ 858,143 $ 225,127 $ 796 $ 988 $ (963,703) $ 166 $ 121,517
Balance at end of period (in shares) at Dec. 31, 2022 377,515,391